European Society of Cardiology

Novartis, Leqvio, Lowering Cholesterol, European Society of Cardiology,atherosclerotic cardiovascular disease

Novartis Unveils Breakthrough Long-Term Data: Leqvio Sustains LDL-C Reduction Beyond Six Years in ESC 2023

Anika Sharma

In the world of medical innovation, where the quest to tame cardiovascular risk is a relentless endeavor, Novartis unfurls a ...

BridgeBio Pharma, Amyloidosis, Clinical trial results, Acoramidis, European Society of Cardiology, Transthyretin amyloid cardiomyopathy

BridgeBio Exposes Phase 3 Acoramidis Insights, Mortality Figures

Anika Sharma

In the intricate dance of scientific exploration, BridgeBio has taken a resolute plunge into the depths of phase 3 acoramidis ...

AstraZeneca, Farxiga, heart failure, Chronic kidney diseases, European Society of Cardiology

Unveiling the Intricate Symphony: AstraZeneca’s Farxiga at the Heart of Cardiorenal Insights

Anika Sharma

In the heart of Amsterdam, amidst the captivating backdrop of the European Society of Cardiology (ESC) scientific sessions, AstraZeneca wielded ...

European Society of Cardiology, Bristol Myers Squibb, Pfizer, Anticoagulant, Eliquis, Rivaroxaban, Apixaban

Exploring Real-World Anticoagulant Transitions: Insights Unveiled at the European Society of Cardiology (ESC) Congress 2023

Anika Sharma

Amidst the vivid tapestry of medical advancements, a pivotal revelation has emerged from the collaborative efforts of the Bristol Myers ...

Amgen, Cardiovascular, Olpasiran, European Society of Cardiology, small interfering RNA, High Cholesterol

Amgen’s Groundbreaking Discovery: Unleashing the Potential of Olpasiran Beyond Expectations

Anika Sharma

In a revelation that promises to reshape the landscape of cardiovascular health, biotechnology giant Amgen has unveiled extraordinary findings from ...